Literature DB >> 14994132

Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children.

Floyd H Gilles1, C Jane Tavaré, Alan Leviton, E Tessa Hedley-Whyte, Anna Sotrel, Lester Adelman, Richard L Davis, Lucy B Rorke.   

Abstract

The Daumas-Duport grading scheme (DDGS) utilizes four histologic features in an additive method (grade 1 if none present, grade 2 if only one is present, etc.). Its efficacy in achieving prognostically homogeneous groups of childhood infratentorial neuroglial tumors and its concordance with World Health Organization (WHO) diagnoses has not been evaluated. We investigated these questions using the Childhood Brain Tumor Consortium (CBTC) database of 1241 neuroglial tumors limited to the infratentorial compartment. We calculated survival function estimates for various DDGS grades as well as the histologic features within each grade. The feature of endothelial prominence improved survival expectation, whereas the remaining three features of nuclear atypia, mitoses, and necrosis were associated with worsened survival. Survival estimates for tumors with DDGS grades 2 and 3 did not differ. Some grades contained feature subsets with significantly different survival distributions. The survival distributions of DDGS grade 1, DDGS grade 2 with only endothelial prominence, and DDGS grade 3 with nuclear atypia and endothelial prominence were not significantly different. DDGS grade within WHO diagnoses had no significant effect on survival expectation. We conclude that grading by summation of only four histologic features, as in the DDGS, is inappropriate for assessment of childhood neuroglial tumors. A classification scheme considering the complete histologic content is more likely to provide clinically useful diagnoses. Such a scheme, based on the CBTC database is available. This scheme uses 26 histologic features identified as reliable in read-reread studies.

Entities:  

Mesh:

Year:  2004        PMID: 14994132     DOI: 10.1007/s10024-003-6072-0

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  2 in total

1.  Elevated citrate in pediatric astrocytomas with malignant progression.

Authors:  Stefan Blüml; Ashok Panigrahy; Mikhail Laskov; Girish Dhall; Mark D Krieger; Marvin D Nelson; Jonathan L Finlay; Floyd H Gilles
Journal:  Neuro Oncol       Date:  2011-07-19       Impact factor: 12.300

2.  Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez.

Authors:  Federico Sánchez-Herrera; Eduardo Castro-Sierra; Luis Felipe Gordillo-Domínguez; Miguel Angel Vaca-Ruiz; Blanca Santana-Montero; Mario Perezpeña-Diazconti; Vicente González-Carranza; Samuel Torres-García; Fernando Chico-Ponce de León
Journal:  Childs Nerv Syst       Date:  2009-01-16       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.